ArticleBreast cancer research : BCR2026
Experimental evaluation of dermal lymphatics in preservation of lymphatic function.
Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSecondary lymphedema is characterized by limb swelling following lymphatic disruption. This results in decreased lymph flow through the collecting ducts and dermal backflow in the subdermal lymphatics. The role of dermal lymphatics in the development of lymphedema is poorly understood. The purpose of this study is to evaluate the effect of dermal lymphatic preservation in the development of lymphedema in a murine tail experimental model.
methodsA standard murine lymphedema tail model was used as the study control. A 3 mm circumferential excision was performed 20 mm from the base of the tail. Both collecting lymphatics adjacent to the veins were transected (Full Dermal Disruption (FDD), control, n = 6). The experimental group was a modification of the standard model consisting of two hemi circumferential skin excision and collecting lymphatics transection with 3 mm interval (Partial Dermal Disruption (PDD), experimental, n = 8) maintaining continuity of capillary lymphatics. Tail volume measurements, lymphatic clearance with near Infrared Indocyanine Green (ICG) laser lymphangiography, and histology were assessed.
resultsThe PDD group had lower tail volumes compared to FDD till day 28 (p < 0.001). ICG lymphangiography demonstrated better lymphatic clearance in the PDD when compared to FDD (p < 0.001). Reduced dermal thickness (p = 0.004) and collagen deposition (p = 0.008) were observed in PDD. Podoplanin-positive lymphatic vessel density was higher in PDD at the unadjusted level (p = 0.014) but did not meet Bonferroni-corrected significance (α = 0.010).
conclusionThis study demonstrates dermal lymphatics can preserve lymphatic function despite injury to transporting lymphatic channels. Dermal lymphatics may have the potential for lymphedema prevention at the lymphatic injury site.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.